Quantib, a wholly-owned subsidiary of RadNet, has developed a powerful AI tool that can help identify the subtle structural changes that distinguish one type of cognitive decline from another. With a substantial improvement in the quantitative measurements of certain brain structures, Quantib’s AI can help differentiate dementia subtypes and aid diagnosis and disease progression.
Objective assessment of brain changes in longitudinal exams in neurodegenerative disease.
Complete atrophy quantification with longitudinal comparison of quantified brain volumes, including White Matter, Grey Matter, ICV, and CSF, to enable tracking of atrophy development.
Support for white matter hyperintensity segmentation and tracking.
“When we find things that are this beneficial for patients, of course we start using it. There are very exciting ways in which AI is being used to save and improve lives. That is just going to keep getting better and better with these kinds of innovations.”
Suzie Bash, M.D.
Medical Director of Neuroradiology, Beverly Radiology
Want to learn more?
To learn more about RadNet’s AI solution for neuroradiology, click here.